SCHEDULE: Wellington Management Discloses 4.9% Stake in Guardian Pharmacy
Beneficial Ownership Report
Wellington Management Group LLP and its affiliates have disclosed a 4.9% beneficial ownership stake in Guardian Pharmacy Services, Inc. common stock as of June 30, 2025.
Summary
- Wellington Management Group LLP, along with Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP, collectively reported beneficial ownership of 1,107,657 shares of Guardian Pharmacy Services, Inc. Common Stock.
- This aggregate amount represents 4.9% of the class of securities.
- The reporting persons hold 815,159 shares with shared voting power and 1,107,657 shares with shared dispositive power.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously filed statement.
- The filing was made pursuant to Rule 13d-1(b), signifying that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: The filing is a standard beneficial ownership disclosure by an institutional investor, indicating a passive stake below the 5% threshold for a 13D. While not inherently positive or negative for the company's operations, the presence of a large, reputable investor can be seen as a minor positive signal of confidence.
Positives
- The disclosure of a significant stake by a reputable institutional investor like Wellington Management can be viewed positively, indicating confidence in the company's long-term prospects.
Negatives
- No specific negative aspects are detailed in this beneficial ownership filing.
Risks
- The filing itself does not detail specific risks related to the issuer's operations or financial health, as it is a disclosure of beneficial ownership.
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future outlook.
Management Comments
- Wellington Management Group LLP, Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
This filing is a routine disclosure of an institutional investment stake and does not provide specific insights into broader industry trends or competitive dynamics within the pharmacy services sector. It indicates an institutional investor's position in a company operating in this industry.
Stakeholder Impact
- Shareholders: The disclosure provides transparency regarding a significant institutional investor's stake, which can influence investor perception and potentially liquidity.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement (beneficial ownership determination date). |
| 08/12/2025 | Date of filing of the Schedule 13G Amendment No. 1. |
Keywords
Guardian Pharmacy Services, Wellington Management, SEC Filing, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Pharmacy Services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.